lenvatinib plus pembrolizumab for advanced melanoma that progressed on a pd-1 or pd-l1 inhibitor...
Published 3 years ago • 234 plays • Length 6:38Download video MP4
Download video MP3
Similar videos
-
0:56
treating patients with melanoma who progressed on anti-pd-l1 with lenvatinib and pembrolizumab
-
6:05
leap-004: lenvatinib pembrolizumab for patients with advanced melanoma and confirmed progressi...
-
6:49
lenvatinib plus pembrolizumab versus soc for previously treated metastatic colorectal cancer
-
2:21
lba44 - lenvatinib plus pembrolizumab for advanced melanoma
-
4:22
melanoma immunotherapy latest and tvec plus pembrolizumab
-
2:41
leap-011: exploring first-line pembrolizumab lenvatinib for advanced urothelial carcinoma
-
9:40
reducing recurrence of advanced melanoma with pembrolizumab
-
6:00
leap-004: initial results
-
3:52
pembrolizumab and indoximod for melanoma
-
10:39
developments with pd1 and immunotherapy in melanoma
-
10:36
results of keynote-054; melanoma patients treated with pembrolizumab
-
10:42
what is new in melanoma?
-
1:20
neopele: neoadjuvant pembrolizumab and lenvatinib in resectable stage iii melanoma
-
4:36
dr. van akkooi on crossover or rechallenge with pembrolizumab in patients with resected melanoma
-
3:01
pembrolizumab: new weapon in the fight against melanoma?
-
42:29
advanced melanoma
-
2:21
lba41 - leap-005: phase ii study of lenvatinib plus pembrolizumab
-
26:50
esmo 2020 melanoma roundup
-
1:10
pembrolizumab: a promising agent for the treatment of mm